NCT06292741 · RECRUITING
Autonomic Involvement in Patient With Cognitive Decline
This study uses a device called Sudoscan to measure how well the autonomic nervous system works in people with different kinds of cognitive decline. That system controls things like sweating and blood pressure. Researchers will compare results across groups. It is not a treatment trial, and no phase applies. Details are limited so far.
You may qualify if
- male and females between 50 and 85 years
- cognitive decline (dementia, lewy's body dementia, Parkinson dementia, Alzheimer dementia)
- mild cognitive decline ( lewy's body MCI, Parkinson MCI and Alzheimer MCI)
- Ability to assume the upright position
You're excluded if
- diabetes mellitus
- eye problems
- severe cognitive decline
- heart disease
- peripheral neuropathy
- language barrier
- oncological disease
- medical pathologies associated with cognitive deficits
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2026-09-02